# Trends in outpatient healthcare visits among adults aged 50 years and older in 27 European countries: analysis of population-based survey data, 2004–2022

**Authors:** Văn Kính Nguyễn, Anna Reuter, Mirna Abd El Aziz, Till Bärnighausen

PMC · DOI: 10.1016/j.lanepe.2025.101407 · The Lancet Regional Health - Europe · 2025-09-24

## TL;DR

This study tracks outpatient healthcare visits for older adults in Europe from 2004 to 2022, showing a pandemic-related decline followed by partial recovery, with chronic disease patients still seeing fewer visits.

## Contribution

The study provides cross-country evidence on outpatient care trends for older Europeans, including pandemic impacts and recovery patterns.

## Key findings

- Outpatient visits for older adults dropped significantly during the pandemic but mostly recovered by 2022.
- Individuals with chronic conditions like diabetes and lung disease continued to have lower post-pandemic visit rates.
- Pre-pandemic visit rates varied widely across European countries, with Luxembourg having the highest and Sweden the lowest.

## Abstract

Understanding trends in healthcare utilisation is key to policy and planning, especially after a prolonged pandemic that led to shutdowns of services in many societal sectors. The aim of this study is to provide comprehensive, cross-country evidence on long-term outpatient care trajectories for the older population in Europe.

We used longitudinal data from 147,116 individuals aged 50 years or older in 27 European countries from the Survey of Health, Ageing and Retirement in Europe (SHARE). We divided the data into three phases: pre-pandemic (2004–2019), pandemic (2021; 2020 excluded due to changes in data collection), and post-pandemic (2022). We used a Bayesian spatiotemporal model to analyse the number of outpatient healthcare visits by sex (male/female) over time and to establish their association with age and chronic conditions.

From 2004 to 2019, the rate of outpatient healthcare visits for a reference individual (defined as 75 years old with no chronic conditions) varied more than threefold across European countries: For men, visits were lowest in Sweden in 2004, with 1.52 [95% uncertainty interval (UI): 1.45–1.61] visits, and highest in Luxembourg in 2019, with 4.62 [4.30–4.90] visits. For women, visits were also lowest in Sweden in 2004 (1.82 [1.74–1.89]) and highest in Luxembourg in 2019 (5.60 [5.20–5.97]). During COVID-19, healthcare visits of men ranged between 0.06 [0.06–0.07] in Italy and 0.45 [0.41–0.49] in Germany, relative to the rate expected without the pandemic. For women, the relative rate ranged between 0.05 [0.05–0.06] in Italy and 0.42 [0.39–0.45] in Germany. Relative reductions were larger for older adults and those with chronic conditions. After COVID-19, the rates of outpatient healthcare visits mostly returned to pre-pandemic levels, but they remained significantly lower for individuals with cardiovascular disease, diabetes, and chronic lung disease.

We show that outpatient healthcare visits for older adults in most European countries declined substantially during the COVID-19 pandemic, but have since then mostly recovered back to their pre-pandemic levels. An important exception to the general recovery of healthcare visits after the pandemic is people living with chronic conditions, who have continued to utilise healthcare at lower levels than in the pre-pandemic era. Policy innovations are needed to ensure that chronic disease patients re-engage with care after major health systems disruptions.

Research in this article is a part of the European Union’s H2020 SHARE COVID-19 project (Grant Agreement No. 101015924).

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995), diabetes (MONDO:0005015)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), chronic lung disease (MESH:D029424), disease (MESH:D004194), COVID-19 (MESH:D000086382), cardiovascular disease (MESH:D002318)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12541641/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12541641/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12541641/full.md

---
Source: https://tomesphere.com/paper/PMC12541641